Skip to main content

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 4 Comparisons of treatment effects: a network meta-analysis

From: Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and network meta-analysis

Treatment

Within 2 months

At last follow-up

N

Mean

95 % CI

P value

N

Mean

95 % CI

P value

VAS

 PRP

153

3.64

2.84, 4.45

<0.001*

168

2.27

1.51, 3.02

<0.001*

 AB

132

2.99

2.19, 3.80

<0.001*

132

2.90

2.09, 3.70

<0.001*

 Steroid

79

4.18

3.04, 5.33,

<0.001*

94

4.29

3.31, 5.27

<0.001*

Treatment

Within 2 months

At last follow-up

N

Mean difference

95 % CI

P value

N

Mean difference

95 % CI

P value

VAS

 PRP vs. steroid

−0.54

−1.76, 0.68

0.386

−2.02

−3.04, −1.01

<0.001*

 AB vs. steroid

−1.19

−2.41, 0.03

0.056

−1.39

−2.48, −0.30

0.012*

 PRP vs. AB

0.65

−0.21, 1.51

0.138

−0.63

−1.47, 0.20

0.138

Treatment

Within 2 months

At last follow-up

 

N

Mean

95 % CI

P value

N

Mean

95 % CI

P value

DASH

 PRP

51

46.15

35.37, 56.93

<0.001*

66

17.38

8.42, 26.33

<0.001*

 AB

30

7.49

−7.61, 22.59

<0.001*

30

7.49

−7.61, 22.59

<0.001*

 Steroid

79

31.76

22.81, 40.71

<0.001*

94

35.95

28.10, 43.80

<0.001*

Treatment

Within 2 months

At last follow-up

N

Mean difference

95 % CI

P value

N

Mean difference

95 % CI

P value

DASH

 PRP vs. steroid

14.39

1.77, 27.00

0.025*

−18.58

−29.08, −8.08

0.001*

 AB vs. steroid

−24.27

−40.68, −7.86

0.004*

−24.27

−40.68, −7.86

0.004*

 PRP vs. AB

38.66

20.48, 56.83

<0.001*

9.88

−7.32, 27.08

0.260

Treatment

Within 2 months

At last follow-up

N

Mean

95 % CI

P value

N

Mean

95 % CI

P value

PRTEE

 PRP

100

36.37

24.09, 48.66

<0.001*

100

29.31

17.03, 41.60

<0.001*

 AB

100

34.12

21.84, 46.41

<0.001*

100

33.87

21.59, 46.16

<0.001*

 Steroid

50

30.82

18.53, 43.11

<0.001*

50

32.53

20.24, 44.82

<0.001*

Treatment

Within 2 months

At last follow-up

N

Mean difference

95 % CI

P value

N

Mean difference

95 % CI

P value

PRTEE

 PRP vs. steroid

5.55

−6.65, 17.76

0.373

−3.22

−15.42, 8.99

0.605

 AB vs. steroid

3.30

−8.90, 15.51

0.596

1.34

−10.86, 13.55

0.829

 PRP vs. AB

2.25

−9.96, 14.46

0.718

−4.56

−16.77, 7.65

0.464

Treatment

Within 2 months

At last follow-up

N

Mean

95 % CI

P value

N

Mean

95 % CI

P value

PPT

 PRP

58

18.58

12.66, 24.51

<0.001*

58

20.03

14.11, 25.96

<0.001*

 AB

30

21.23

15.16, 27.31

<0.001*

30

27.53

21.46, 33.61

<0.001*

 Steroid

88

17.57

11.70, 23.44

<0.001*

88

17.67

11.80, 23.54

<0.001*

Treatment

Within 2 months

At last follow-up

N

Mean difference

95 % CI

P value

N

Mean difference

95 % CI

P value

PPT

 PRP vs. steroid

1.02

−0.48, 2.52

0.184

2.37

0.87, 3.87

0.02*

 AB vs. steroid

3.67

1.64, 5.69

<0.001*

9.87

7.84, 11.89

<0.001*

 PRP vs. AB

−2.65

−5.00, −0.30

<0.001

−7.50

−9.85, −5.15

<0.001*

Treatment

Within 2 months

At last follow-up

N

IR

95 % CI

P value

N

IR

95 % CI

P value

Adverse effects

 PRP

85

0.10

0.03, 0.34

<0.001*

 AB

74

0.20

0.06, 0.65

0.008*

 Steroid

129

0.11

0.03, 0.35

<0.001*

Treatment

Within 2 months

At last follow-up

N

RR

95 % CI

P value

N

RR

95 % CI

P value

Adverse effects

 PRP vs. steroid

0.90

0.36, 2.24

0.821

 AB vs. steroid

1.88

0.95, 3.72

0.068

 PRP vs. AB

0.004

0.0002, 0.09

0.001*

  1. PRP platelet-rich plasma, AB autologous blood, Steroid corticosteroid, VAS visual analog score, DASH Disabilities of the Arm Shoulder and Hand, PRTEE Patient-Rated Tennis Elbow Evaluation, PPT pressure pain threshold, CI confidence interval, IR incident rate, RR relative risk
  2. * Statistically significant difference (P < 0.05)